Released | Company | Title | Industry | Topic |
---|---|---|---|---|
21 Oct 2021 12:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2021 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
14 Sep 2021 08:34 CEST |
VISTIN PHARMA | Mandatory notification of trade in Vistin Pharma ASA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
19 Aug 2021 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2021 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
12 Aug 2021 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2021 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
21 May 2021 08:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Ex dividend NOK 0.5 today | 20103015 Pharmaceuticals | Ex Date |
20 May 2021 14:55 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the annual general meeting 2021 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
19 May 2021 08:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
04 May 2021 08:50 CEST |
VISTIN PHARMA | CORRECTION: Vistin Pharma ASA : Key information relating to the cash dividend | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
30 Apr 2021 11:22 CEST |
VISTIN PHARMA | Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
28 Apr 2021 12:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA : Call for annual general meeting | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2021 12:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Annual Report for 2020 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
23 Apr 2021 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2021 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
16 Apr 2021 15:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2021 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |